Takeda Divests Europe OTCs In $670m Deal As Rumors Swirl Of Japan Biz Sale

Takeda will divest a portfolio containing OTC drugs and dietary supplements to Denmark's Orifarm, while rumors suggest the company is poised to offload its substantial Japanese consumer healthcare business.